Thermo Fisher Scientific (TMO) PT Raised to $539 at Needham & Company; 'COVID-19 Testing Revenue Should Drive Exceptional Growth Well Into 2021'
Tweet Send to a Friend
Needham & Company analyst Stephen Unger raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $539.00 while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
